The Economic Standard: Rx Importation Poses a Threat to Consumers, Not a Solution

According to the GoodRx Research Team, 832 brand drugs have increased by an average of 4.5% since December 31, 2020. Americans pay around $1,200 for prescription drugs a year. The continuing rise of prescription drug prices has a significant impact on many Americans, especially during a global pandemic. In the latest PawnGuru poll, about 20% of respondents say they […]

E-Cigarette Taxes Keep Smokers Smoking

The Tobacco Tax Equity Act of 2021 (TTEA) was introduced at the end of April in both Houses of Congress by U.S. Senators Dick Durbin (D-IL).Ron Wyden (D-OR), and Representative Raja Krishnamoorthi (IL-D-08). If passed, the bill would establish new tax rates on both e-cigarette and tobacco products potentially causing an increase in the smoking […]

Podcast: Short-and Long-Term Implications of Waiving IP Protections for COVID-19 Related Drugs and Technologies – with Andrei Iancu

India, South Africa, and other developing countries are leading the push for a waiver of the Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) under the rationale that it’s the only way to ensure equitable and affordable access to COVID vaccines.  In this podcast episode, Andrei Iancu, former undersecretary of Commerce for intellectual property (IP) […]

TOWNHALL: Waiving TRIPS Will Not Solve Global Access to COVID-19 Vaccine

While the objective of waiving the provisions of the TRIPS agreement is admirable, it should be readily apparent to policymakers in Washington and the WTO that loosening intellectual property protections will not expedite vaccine manufacturing or distribution in economically developing countries. These countries do not possess the facilities to manufacture and distribute vaccines themselves. To […]

Will Banning Menthol Help Smokers Quit?

The Food and Drug Administration (FDA) recently took the bold step of announcing plans to ban the sale of menthol flavored tobacco. The agency unveiled its decision guided by the belief that prohibiting access will “help save lives, particularly among those disproportionately affected by these deadly products.” With flavored e-cigarettes being banned since February of […]

Letter to the Nevada Senate: Price Controls on Lower Cost Drugs is a Bad Idea

Dear Chairwoman Carlton: As a non-profit research organization representing consumers in Nevada and around the United States, we strongly oppose Nevada Senate Bill 380 (SB 380). As your Committee seeks much-needed remedies to the rising cost of health care, and specifically prescription drugs, we encourage you to resist efforts that directly or indirectly impose price […]

Townhall: Price Controls Will Kill Pharmaceutical R&D

While imposing price controls on prescription medications may be well-intentioned, it should be clear to legislators that a move in that direction will only create a new set of intractable problems for American patients. Rather than being unable to afford medications, patients could be denied access to future drugs as well as those already on […]

AI Offers Substantial Benefits for Patients

On April 21, the European Commission released its much-anticipated proposal for a regulation laying down harmonized rules on artificial intelligence. If implemented, Brussels’ proposal would govern artificial intelligence (AI) across 27 member countries and for over 445 million people. In outlining the need for the Commission’s proposed AI regulations, Margrethe Vestager, Executive Vice-President for a Europe fit for […]

Telehealth Needs Legislative Support, Not Financial Handouts

In 2020, the use of telehealth exploded. The American Journal of Managed Care estimated between September 2019 and September 2020, telehealth visits increased by a staggering 2980%. This growth was driven by the uncontrolled spread of Coronavirus, the convenience of virtual care compared to traditional in-person visits, lower costs for patients, the temporary waiving of regulatory requirements that increased the supply […]